HomeCompareSVTMF vs MRK

SVTMF vs MRK: Dividend Comparison 2026

SVTMF yields 2.12% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SVTMF wins by $81.98M in total portfolio value· pulled ahead in Year 2
10 years
SVTMF
SVTMF
● Live price
2.12%
Share price
$11.00
Annual div
$0.23
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$82.04M
Annual income
$75,213,139.59
Full SVTMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SVTMF vs MRK

📍 SVTMF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSVTMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SVTMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SVTMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SVTMF
Annual income on $10K today (after 15% tax)
$179.89/yr
After 10yr DRIP, annual income (after tax)
$63,931,168.65/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SVTMF beats the other by $63,922,840.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SVTMF + MRK for your $10,000?

SVTMF: 50%MRK: 50%
100% MRK50/50100% SVTMF
Portfolio after 10yr
$41.05M
Annual income
$37,611,468.87/yr
Blended yield
91.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SVTMF
No analyst data
Altman Z
1.7
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SVTMF buys
0
MRK buys
0
No recent congressional trades found for SVTMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSVTMFMRK
Forward yield2.12%2.76%
Annual dividend / share$0.23$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$82.04M$56.8K
Annual income after 10y$75,213,139.59$9,798.13
Total dividends collected$81.50M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SVTMF vs MRK ($10,000, DRIP)

YearSVTMF PortfolioSVTMF Income/yrMRK PortfolioMRK Income/yrGap
1$11,123$423.27$11,206$366.19$83.00MRK
2← crossover$12,782$880.03$12,650$502.35+$132.00SVTMF
3$15,567$1,890.21$14,407$694.19+$1.2KSVTMF
4$20,959$4,302.89$16,585$967.82+$4.4KSVTMF
5$33,256$10,828.92$19,342$1,363.89+$13.9KSVTMF
6$67,699$32,115.54$22,913$1,947.19+$44.8KSVTMF
7$194,640$122,202.36$27,662$2,823.89+$167.0KSVTMF
8$864,979$656,714.27$34,159$4,173.35+$830.8KSVTMF
9$6,380,540$5,455,012.61$43,337$6,308.80+$6.34MSVTMF
10$82,040,318$75,213,139.59$56,776$9,798.13+$81.98MSVTMF

SVTMF vs MRK: Complete Analysis 2026

SVTMFStock

SM Investments Corporation, together with its subsidiaries, engages in the property, retail, and banking and other businesses in the Philippines. The company's Property segment is involved in the mall, residential, and commercial development, as well as the operation of hotels and convention centers. This segment also develops, conducts, operates, and maintains commercial shopping centers, as well as conducts, operates, and maintains shopping center spaces, amusement centers, and cinema theaters within the shopping centers. In addition, it engages in the development and transformation of residential, commercial, entertainment, and tourism districts. As of December 31, 2021, it operated 78 malls in the Philippines with a total gross floor area (GFA) of 8.9 million square meters; and 7 malls in China with a total GFA of 1.3 million square meters. Its Retail segment is involved in the retail/wholesale trading of merchandise, such as dry goods, wearing apparels, food, and other merchandise. As of December 31, 2021, this segment operated 3,215 stores, including 68 SM stores, 61 SM supermarkets, 214 Savemore stores, 52 SM hypermarkets, 7 WalterMart stores, 1,207 Alfamart stores, and 1 Mindpro store, as well as 1,539 specialty stores. The company's Banking and Others segment engages in asset management and capital investments, as well as provision of financial services. It provides lending; deposit-taking; foreign exchange; brokering; trust and investments; credit cards; corporate cash management and remittances; leasing and financing; life insurance; and insurance and stock brokerage services, as well as investment, private, and rural banking services. This segment operates approximately a network of 1,500 branches and 4,400 ATMs. The company also invests in other sectors, such as commercial buildings, leisure, logistics, food manufacturing, and mining. SM Investments Corporation was founded in 1958 and is headquartered in Pasay City, the Philippines.

Full SVTMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SVTMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SVTMF vs SCHDSVTMF vs JEPISVTMF vs OSVTMF vs KOSVTMF vs MAINSVTMF vs JNJSVTMF vs ABBVSVTMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.